Skip to main content
Top

Advances in Therapy

Issue 9/2009

Content (7 Articles)

Review

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

David Montani, Marie-Camille Chaumais, Laurent Savale, Delphine Natali, Laura C. Price, Xavier Jaïs, Marc Humbert, Gérald Simonneau, Olivier Sitbon

Original Research

Cost of atrial fibrillation in United States managed care organizations

Michael H. Kim, Jay Lin, Mohamed Hussein, Charles Kreilick, David Battleman

Original Research

Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis

Joerg Gruenwald, Ellen Petzold, Regina Busch, Heinz-Peter Petzold, Hans-Joachim Graubaum

Original Research

An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice

Lucas M. A. Goossens, Roland A. Riemersma, Dirkje S. Postma, Thys van der Molen, Maureen P. M. H. Rutten-van Mölken

Original Research

Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer

Shilian Hu, Gan Shen, Shi Yin, Weiping Xu, Bing Hu

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine